Association between FCGR2A rs1801274 and MUC5B rs35705950 variations and pneumonia susceptibility

Xueshu Shi1, Yue Ma2, Haiyan Li3

  • 1Nursing Division, The second affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300150, P.R. China.

BMC Medical Genetics
|April 8, 2020
PubMed
Abstract

Insights

Genetic variations in MUC5B rs35705950 significantly increase pneumonia susceptibility, particularly idiopathic pulmonary fibrosis. FCGR2A rs1801274 showed no association with pneumonia risk in this meta-analysis.

Area of Science:

  • Genetics
  • Pulmonology
  • Epidemiology

Background:

  • Pneumonia susceptibility is influenced by genetic factors.
  • The roles of FCGR2A rs1801274 and MUC5B rs35705950 in pneumonia risk require comprehensive evaluation.
  • Published data on these genetic variations and pneumonia are fragmented.

Purpose of the Study:

  • To conduct a meta-analysis evaluating the impact of FCGR2A (Fc fragment of IgG receptor IIa) rs1801274 and MUC5B (mucin 5B, oligomeric mucus/gel-forming) rs35705950 variations on pneumonia susceptibility.
  • To pool data from existing case-control studies for robust statistical analysis.
  • To clarify the association between these specific genetic markers and the risk of developing pneumonia.

Main Methods:

  • Systematic retrieval of case-control studies from multiple online databases.
  • Application of meta-analysis techniques for pooling and analyzing genetic association data.
  • Inclusion of fourteen studies for FCGR2A rs1801274 and thirty-one studies for MUC5B rs35705950.

Main Results:

  • No significant association was found between FCGR2A rs1801274 and pneumonia susceptibility.
  • MUC5B rs35705950 demonstrated a significant association with increased pneumonia susceptibility across various genetic models (allelic, carrier, homozygous, heterozygous).
  • Subgroup analyses confirmed the positive association for MUC5B rs35705950 in Caucasian and Asian populations, and for idiopathic pulmonary fibrosis.

Conclusions:

  • The MUC5B rs35705950 polymorphism is a significant risk factor for pneumonia, especially idiopathic pulmonary fibrosis.
  • FCGR2A rs1801274 does not appear to influence susceptibility to clinical pneumonia.
  • These findings highlight the importance of MUC5B rs35705950 in respiratory disease pathogenesis across diverse populations.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.7K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.4K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
646
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.2K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.1K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
643